Developing a zebrafish model of bisphosphonate induced osteonecrosis of jaw to define cellular and molecular mechanisms
Bisphosphonates are critical drugs of the orthopaedic clinic, which act by inhibiting osteoclast resorptive activity and thus promote bone density. They are commonly used for treating Osteogenesis Imperfecta (OI), Paget’s disease, osteoporosis, and bone metastasis. In particular, the global rise in...
Main Author: | Ethiraj, Lalith Prabha |
---|---|
Other Authors: | Tom James Carney |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/168636 |
Similar Items
-
Bisphosphonates and osteonecrosis of the jaw /
by: Bilezikian, John P., et al.
Published: (2011) -
BISPHOSPHONATE INDUCED OSTEONECROSIS OF THE JAWS AND CURRENT THERAPIES
by: Damla Torul, et al.
Published: (2017-08-01) -
Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01) -
Bisphosphonate-related osteonecrosis of the jaw: An insight
by: Shalini Kapoor, et al.
Published: (2013-01-01) -
BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW AND DENTAL IMPLANTS
by: Ala Hassan A. Qamheya, et al.
Published: (2016-01-01)